Literature DB >> 29070479

[Current progress in research of circulating tumor cells].

Qian-Wen Zhao1, Bo Situ, Lei Zheng.   

Abstract

OBJECTIVE: Circulating tumor cells are tumor cells that spontaneously or, following operations, migrate into the peripheral blood circulation from the primary tumor or metastatic tumor. As diagnostic, prognostic and predictive biomarkers in many types of cancers including breast cancer, lung cancer, pancreatic cancer and colorectal cancer, circulating tumor cells contribute to the early diagnosis of cancers, drug resistance monitoring, prognostic assessment, survival analysis, detection of tumor recurrence and evaluation of drug efficacy to assist in treatment decision?making and adjustment of treatment plans. However, the current approaches to the detection of circulating tumor cells still have limitations, and the development of new detection methods with higher sensitivity and specificity will be helpful for better use of these cells. Herein the authors review the research progress in circulating tumor cells in terms of the detection techniques, clinical applications of circulating tumor cells, and their prospects in future clinical practice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29070479      PMCID: PMC6743959     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  42 in total

Review 1.  Gene expression profiling and DNA methylation analyses of CTCs.

Authors:  Evi S Lianidou
Journal:  Mol Oncol       Date:  2016-02-05       Impact factor: 6.603

2.  Circulating tumour cells go green.

Authors:  Robert M Hoffman
Journal:  Gut       Date:  2014-10-23       Impact factor: 23.059

3.  Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.

Authors:  Jie-Fu Chen; Hao Ho; Jake Lichterman; Yi-Tsung Lu; Yang Zhang; Mitch A Garcia; Shang-Fu Chen; An-Jou Liang; Elisabeth Hodara; Haiyen E Zhau; Shuang Hou; Rafi S Ahmed; Daniel J Luthringer; Jiaoti Huang; Ker-Chau Li; Leland W K Chung; Zunfu Ke; Hsian-Rong Tseng; Edwin M Posadas
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

4.  Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations.

Authors:  Reza M Mohamadi; Justin D Besant; Adam Mepham; Brenda Green; Laili Mahmoudian; Thaddeus Gibbs; Ivaylo Ivanov; Anahita Malvea; Jessica Stojcic; Alison L Allan; Lori E Lowes; Edward H Sargent; Robert K Nam; Shana O Kelley
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-05       Impact factor: 15.336

5.  Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

Authors:  J Tol; M Koopman; M C Miller; A Tibbe; A Cats; G J M Creemers; A H Vos; I D Nagtegaal; L W M M Terstappen; C J A Punt
Journal:  Ann Oncol       Date:  2009-10-27       Impact factor: 32.976

Review 6.  Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.

Authors:  Ramdane Harouaka; Zhigang Kang; Si-Yang Zheng; Liang Cao
Journal:  Pharmacol Ther       Date:  2013-10-14       Impact factor: 12.310

7.  Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study.

Authors:  Marta Pestrin; Silvia Bessi; Fabio Puglisi; Alessandro M Minisini; Giovanna Masci; Nicola Battelli; Alberto Ravaioli; Lorenzo Gianni; Roberta Di Marsico; Carlo Tondini; Stefania Gori; Charles R Coombes; Justin Stebbing; Laura Biganzoli; Marc Buyse; Angelo Di Leo
Journal:  Breast Cancer Res Treat       Date:  2012-04-04       Impact factor: 4.872

8.  A cancer cell-activatable aptamer-reporter system for one-step assay of circulating tumor cells.

Authors:  Zihua Zeng; Ching-Hsuan Tung; Youli Zu
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-12       Impact factor: 10.183

9.  Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.

Authors:  J S Ankeny; C M Court; S Hou; Q Li; M Song; D Wu; J F Chen; T Lee; M Lin; S Sho; M M Rochefort; M D Girgis; J Yao; Z A Wainberg; V R Muthusamy; R R Watson; T R Donahue; O J Hines; H A Reber; T G Graeber; H R Tseng; J S Tomlinson
Journal:  Br J Cancer       Date:  2016-06-14       Impact factor: 7.640

Review 10.  Circulating tumor cells in breast cancer.

Authors:  Francois-Clement Bidard; Charlotte Proudhon; Jean-Yves Pierga
Journal:  Mol Oncol       Date:  2016-01-12       Impact factor: 6.603

View more
  1 in total

1.  Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.

Authors:  Tao Bai; Rongyun Mai; Jiazhou Ye; Jie Chen; Lunan Qi; Juan Tang; Meng Wei; Lianda Zhang; Zhiwei Chen; Zhihong Tang; Lequn Li; Feixiang Wu
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.